Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONALEESA-1: Ribociclib + Letrozole in Early Breast Cancer
NCT01919229Phase 2Terminated
- Sponsor
- Novartis
- Start
- Oct 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ribociclib in breast cancer, sponsored by Novartis. Started Oct 2013; status: terminated.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01919229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919229.